Multiple sclerosis (MS) is a chronic neurodegenerative and autoimmune disease. Motor,
sensory and cognitive deficits in MS are commonly accompanied by psychiatric disorders …

Introduction: The interactions between Diabetes Mellitus type II (DMII) and Multiple Sclerosis
(MS) lead to higher levels of fatigue, higher risk of physical disability, faster cognitive …

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the
central nervous system characterized by broad inter-and intraindividual heterogeneity and …

Objectives Investigation of the comorbidity burden in persons with multiple sclerosis (PwMS)
has become increasingly important. The aim of this study was to investigate the relationships …

Multiple sclerosis (MS) is a chronic, inflammatory, degenerative demyelinating disease of
the central nervous system (CNS) of unknown etiology that affects individuals in their early …

Introduction: The successful development of anti-inflammatory disease-modifying treatments
(DMT) significantly improved disease outcomes and longevity of persons with multiple …

Background Due to the demographic development and improved treatment options, the role
of comorbidities is of increasing importance in the medical care of people with MS (pwMS). A …

Background and purpose This study was undertaken to identify clinically meaningful
comorbidity patterns and their associations with the demographic/clinical characteristics of …

Background and purpose Comorbidities are common in multiple sclerosis (MS), and have
been associated with worse outcomes and increased health care resource usage. We …

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system
characterized by inflammation, demyelination, and neurodegeneration. It mainly affects …